Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

KN046 in Subjects With Advanced Solid Tumors and Lymphoma

NCT03733951

Conditions
Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Completed

Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas

NCT03311412

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01027000

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States
View all 25 locations
View Trial Details
Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions